National Center for Register-Based Research, Aarhus University, Aarhus, Denmark.
Center for Integrated Register-Based Research, Aarhus University, Aarhus, Denmark.
Ann Neurol. 2019 Dec;86(6):951-961. doi: 10.1002/ana.25623. Epub 2019 Oct 31.
To examine whether prior suicidal behavior and familial predisposition to psychiatric disorders modify the association between antiepileptic drug use and completed suicide.
Using the Danish National Prescription Register, we identified all incident users of antiepileptic drugs aged 15 years or older in Denmark between July 1997 and December 2015. We carried out a nested case-control study and defined exposure to antiepileptic drugs at the index date (ie, time of suicide). Conditional logistic regressions were used to estimate mortality rate ratios (MRRs) of suicide in current versus previous users of antiepileptic drugs. We also analyzed suicide risk associated with the 9 most commonly used antiepileptic drugs.
We identified 1,759 individuals completing suicide. Current versus previous use of any antiepileptic drug was associated with an increased risk of suicide (MRR = 1.26, 95% confidence interval [CI] = 1.13-1.40). This excess risk was observed in individuals with a history of suicidal behavior (MRR = 1.28, 95% CI = 1.07-1.54) and in those without (MRR = 1.26, 95% CI = 1.11-1.43), and in individuals with a familial predisposition to psychiatric disorders (MRR = 1.48, 95% CI = 1.18-1.87) and in those without (MRR = 1.21, 95% CI = 1.07-1.35).
Use of antiepileptic drugs was associated with an increased risk of suicide. The findings do not support that the risk of suicide following treatment with antiepileptic drugs identified in randomized trials is explained by prior suicidality or familial predisposition to psychiatric disorders. The additional risk of suicide associated with use of antiepileptic drugs was generally low and should be balanced against benefits of treatment. ANN NEUROL 2019;86:951-961.
研究既往自杀行为和精神障碍家族易感性是否会改变抗癫痫药物使用与完成自杀之间的关联。
我们使用丹麦全国处方登记处,确定了 1997 年 7 月至 2015 年 12 月期间丹麦所有年龄在 15 岁或以上的新诊断使用抗癫痫药物的患者。我们进行了一项嵌套病例对照研究,并将暴露于抗癫痫药物定义为指数日期(即自杀时间)。使用条件逻辑回归来估计当前使用与之前使用抗癫痫药物的患者自杀的死亡率比(MRR)。我们还分析了与最常用的 9 种抗癫痫药物相关的自杀风险。
我们确定了 1759 例自杀者。与之前使用相比,当前使用任何抗癫痫药物与自杀风险增加相关(MRR=1.26,95%置信区间[CI]:1.13-1.40)。这种风险增加在有自杀行为史的个体(MRR=1.28,95%CI:1.07-1.54)和无自杀行为史的个体(MRR=1.26,95%CI:1.11-1.43)中均观察到,在有精神障碍家族易感性的个体(MRR=1.48,95%CI:1.18-1.87)和无精神障碍家族易感性的个体(MRR=1.21,95%CI:1.07-1.35)中也观察到。
使用抗癫痫药物与自杀风险增加相关。这些发现不支持随机试验中发现的抗癫痫药物治疗后自杀风险是由既往自杀行为或精神障碍家族易感性引起的。与使用抗癫痫药物相关的额外自杀风险通常较低,应与治疗益处相平衡。